Engineered cationic Interleukin-1 receptor antagonist outperforms anakinra at joint retention and preventing IL-1-induced cartilage inflammation.
- DOI
- 10.1016/j.joca.2025.12.018
- Published
- 2026 Apr
- Container
- Osteoarthritis and cartilage
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.joca.2025.12.018,
title = {Engineered cationic Interleukin-1 receptor antagonist outperforms anakinra at joint retention and preventing IL-1-induced cartilage inflammation.},
author = {Boyer TL and Hakim B and Childress L and Baby HM and Porter RM and Bajpayee AG},
year = {2026},
journal = {Osteoarthritis and cartilage},
doi = {10.1016/j.joca.2025.12.018},
url = {https://doi.org/10.1016/j.joca.2025.12.018}
}RIS
TY - JOUR TI - Engineered cationic Interleukin-1 receptor antagonist outperforms anakinra at joint retention and preventing IL-1-induced cartilage inflammation. AU - Boyer TL AU - Hakim B AU - Childress L AU - Baby HM AU - Porter RM AU - Bajpayee AG PY - 2026 JO - Osteoarthritis and cartilage DO - 10.1016/j.joca.2025.12.018 UR - https://doi.org/10.1016/j.joca.2025.12.018 ER -
APA
TL, B., B, H., L, C., HM, B., RM, P., & AG, B. (2026). Engineered cationic Interleukin-1 receptor antagonist outperforms anakinra at joint retention and preventing IL-1-induced cartilage inflammation.. Osteoarthritis and cartilage. https://doi.org/10.1016/j.joca.2025.12.018
Source records
- pubmed · retrieved 2026-09-25T23:29:44.002Z